Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-09

Clinical Trial Update: Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 Years [Phase 2]

View source ↗

Summary

This Phase 2 follow-up trial update reports five-year outcomes on the use of probiotics affecting atopy, immune responses, and gut microbiota in eczema (atopic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic (probiotic)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Eczema, Asthma | Phase 2 | Status: COMPLETED